ES2007536A6 - Procedimiento para la fabricacion de un conjugado de superoxido dismutasa soluble en agua y sustancialmente no inmunogenico. - Google Patents

Procedimiento para la fabricacion de un conjugado de superoxido dismutasa soluble en agua y sustancialmente no inmunogenico.

Info

Publication number
ES2007536A6
ES2007536A6 ES8802307A ES8802307A ES2007536A6 ES 2007536 A6 ES2007536 A6 ES 2007536A6 ES 8802307 A ES8802307 A ES 8802307A ES 8802307 A ES8802307 A ES 8802307A ES 2007536 A6 ES2007536 A6 ES 2007536A6
Authority
ES
Spain
Prior art keywords
superoxide dismutase
conjugates
polyethylene glycol
glycol
polyalkyleneglycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802307A
Other languages
English (en)
Inventor
Mark Saifer
Ralph Somack
L Dvid Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DDI Pharmaceuticals Inc
Original Assignee
DDI Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DDI Pharmaceuticals Inc filed Critical DDI Pharmaceuticals Inc
Publication of ES2007536A6 publication Critical patent/ES2007536A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE EFECTUA LA PREPARACION DE UN CONJUGADO SUSTANCIALMENTE NO INMUNOGENICO Y SOLUBLE EN AGUA DE SUPEROXIDO DISMUTASA ACOPLANDO A UN POLIALQUILENGLICOL CONSTITUIDO POR POLIETILENGLICOL O COPOLIMERO POLIETILENO-POLIPROPILENGLICOL, EN EL QUE DICHO GLICOL TIENE UN PESO MOLECULAR PROMEDIO DE 30.000-1.000.000 Y ESTA SIN SUSTITUIR TERMINALMENTE O SUSTITUIDO POR GRUPOS C1-4-ALQUILO O C1-4-ALCOXI.
ES8802307A 1987-08-03 1988-07-21 Procedimiento para la fabricacion de un conjugado de superoxido dismutasa soluble en agua y sustancialmente no inmunogenico. Expired ES2007536A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03

Publications (1)

Publication Number Publication Date
ES2007536A6 true ES2007536A6 (es) 1989-06-16

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802307A Expired ES2007536A6 (es) 1987-08-03 1988-07-21 Procedimiento para la fabricacion de un conjugado de superoxido dismutasa soluble en agua y sustancialmente no inmunogenico.

Country Status (17)

Country Link
EP (1) EP0377613B1 (es)
JP (1) JP2515389B2 (es)
KR (1) KR920001426B1 (es)
CN (1) CN1020458C (es)
AU (1) AU608901B2 (es)
CA (1) CA1309046C (es)
DE (1) DE3876997T2 (es)
DK (1) DK160842C (es)
ES (1) ES2007536A6 (es)
HU (1) HU203783B (es)
IE (1) IE64284B1 (es)
IL (1) IL87177A (es)
NZ (1) NZ225481A (es)
PH (1) PH27225A (es)
RU (1) RU1776275C (es)
WO (1) WO1989001033A1 (es)
ZA (1) ZA885249B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0470128B2 (en) † 1989-04-19 2003-08-13 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
EP0598037A1 (en) * 1991-08-05 1994-05-25 Sanofi Buffered formulation of peg-sod
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
AU768765B2 (en) * 1998-06-23 2004-01-08 Novozymes A/S A polypeptide-polymer conjugate
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
WO2000004138A1 (en) * 1998-07-17 2000-01-27 Novozymes A/S A polypeptide-polymer conjugate with improved wash performance
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
EA008866B1 (ru) 2002-12-26 2007-08-31 Маунтин Вью Фамэсьютикэлс, Инк. ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ
BRPI0411160A (pt) * 2003-05-12 2006-07-11 Affymax Inc novos compostos modificados com poli(glicol etilênico) e usos dos mesmos
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
EP0377613A1 (en) 1990-07-18
NZ225481A (en) 1990-11-27
JP2515389B2 (ja) 1996-07-10
HU203783B (en) 1991-09-30
PH27225A (en) 1993-05-04
DE3876997D1 (de) 1993-02-04
IL87177A0 (en) 1988-12-30
HUT52816A (en) 1990-08-28
DK160842B (da) 1991-04-22
DE3876997T2 (de) 1993-04-29
JPH02504341A (ja) 1990-12-13
WO1989001033A1 (en) 1989-02-09
CA1309046C (en) 1992-10-20
AU2326888A (en) 1989-03-01
DK160842C (da) 1991-10-14
KR890701736A (ko) 1989-12-21
CN1020458C (zh) 1993-05-05
RU1776275C (ru) 1992-11-15
ZA885249B (en) 1989-04-26
EP0377613B1 (en) 1992-12-23
IE64284B1 (en) 1995-07-26
IL87177A (en) 1992-08-18
CN1031088A (zh) 1989-02-15
KR920001426B1 (ko) 1992-02-13
IE882206L (en) 1989-02-03
DK392789D0 (da) 1989-08-10
AU608901B2 (en) 1991-04-18
DK392789A (da) 1989-08-10

Similar Documents

Publication Publication Date Title
ES2007536A6 (es) Procedimiento para la fabricacion de un conjugado de superoxido dismutasa soluble en agua y sustancialmente no inmunogenico.
CA2268433A1 (en) Improved interferon polymer conjugates
CA2255637A1 (en) Conjugates of cis-docosahexaenoic acid and paclitaxel
PT855913E (pt) Formulacoes de ferro-dextrano
KR880701564A (ko) 스타버스트 콘쥬게이트
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
CA2289202A1 (en) Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
NZ296452A (en) Conjugates of bdnf or nt-3 and at least one water-soluble polymer
CA2158054A1 (en) Conjugates of proteins and bifunctional ligands
AU7761594A (en) Polyethylene glycols
DE3781760D1 (de) Pulvermischungen auf eisenbasis.
EP0372752A3 (en) Cd4 polypeptide derivatives
MY101658A (en) Absorbent resin with excellent stability
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
KR910009274A (ko) 폴리믹신 복합체
GR1002294B (el) Συνδυασμενο εμβολιο για streptococcus ομαδας β.
AU6477890A (en) Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof incombination with functionalized tumor-specific enzyme conjugates
KR860006542A (ko) 안정화된 효소결합체 조성물
AU6285490A (en) Superoxide dismutase-catalase conjugates
IL95773A0 (en) Polymer compositions comprising graft copolymer impact modifier
AU5981290A (en) Expandable molding compositions having high heat distortion resistance, and the preparation thereof
KR890009386A (ko) 백금화합물 동결건조제제
TW228524B (es)
EP0258053A3 (en) Low wear polyarylate

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060722